Overcoming Current Dilemma in Cartilage Regeneration: Will Direct Conversion Provide a Breakthrough?

Area of Science:

• Cell biology
• Regenerative medicine
• Biotechnology

Background:

• Osteoarthritis (OA) significantly impacts quality of life, with limited disease-modifying treatments.
• Current regenerative strategies for OA face challenges, including rapid cell apoptosis after transplantation.
• Direct conversion offers an alternative to traditional stem cell therapy for OA.

Purpose of the Study:

• To review the current status and potential of direct conversion in regenerative medicine for OA.
• To explore the conceptual strategy and future directions for applying direct conversion in OA treatment.
• To highlight how direct conversion can overcome limitations of existing cell therapies.

Main Methods:

• This perspective review synthesizes existing research on direct conversion and its application in OA.
• It discusses the principles of direct conversion, contrasting it with iPSC-mediated reprogramming.
• The review examines advancements in in vivo gene transfer and biomaterials relevant to direct conversion.

Main Results:

• Direct conversion enables differentiated cells to transform into other cell types without an iPSC stage.
• In vivo direct conversion holds promise for a new era of OA regenerative medicine.
• Advances in gene transfer and biomaterials are paving the way for clinical applications.

Conclusions:

• Direct conversion represents a promising therapeutic strategy for osteoarthritis.
• This approach has the potential to overcome the limitations associated with current cell-based therapies for OA.
• Future advancements in in vivo gene transfer and smart biomaterials could enable the clinical translation of direct conversion for OA treatment.